Autolus Therapeutics plc
AUTL
Positions held
Your positionsAUTL isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $471.11M | Enterprise value | $637.29M | Trailing P/E | — | Forward P/E | -2.82 |
| PEG | — | Price / book | 6.30 | Beta | 2.14 | Dividend yield | 0.00% |
| Revenue growth | 118.4% | Earnings growth | — | Gross margin | -74.6% | Operating margin | -95.9% |
| Profit margin | -2.4% | ROE | -133.0% | ROA | -25.4% | Debt / equity | 4.91 |
| Current ratio | 4.89 | Free cash flow | -$201.19M | Analyst recommendation | strong_buy | Mean target | $8.73 |
| 52w high | $2.58 | 52w low | $1.18 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $45.7M | $26.2M | $24.3M | $21.2M | $20.9M | — |
| Op margin | -95.9% | -227.0% | -298.4% | -337.9% | -292.6% | — |
| Net income | -$39.1M | -$71.6M | -$90.3M | -$79.1M | -$47.9M | — |
| Gross margin | 55.2% | 6.3% | -4.3% | -35.1% | -16.8% | — |
| Gross profit | $25.2M | $1.6M | -$1.0M | -$7.4M | -$3.5M | — |
| Operating income | -$43.8M | -$59.5M | -$72.5M | -$71.6M | -$61.2M | — |
- Revenue +74% vs prior quarter ($46M vs $26M).
- Gross margin 55.2% (was 6.3% prior quarter).
- Operating margin expanded to -96%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $75.4M | $10.1M | $1.7M | $6.2M | — |
| Op margin | -358.9% | -2385.6% | -10337.3% | -2307.0% | — |
| Net income | -$288M | -$221M | -$208M | -$149M | — |
| Gross margin | -27.8% | -12.5% | 100.0% | — | — |
| Gross profit | -$21.0M | -$1.3M | $1.7M | — | — |
| Operating income | -$271M | -$241M | -$176M | -$143M | — |
Headlines — positive tone
• [OK · fundamentals] All You Need to Know About Autolus Therapeutics (AUTL) Rating Upgrade to Buy
News
2026-10-05 · All You Need to Know About Autolus Therapeutics (AUTL) Rating Upgrade to Buy
2026-09-12 · AUCATZYL Sales Are Exploding, But Autolus (AUTL) Still Isn’t In The Black
2026-08-11 · Autolus Therapeutics Q2 Earnings Call Highlights
2026-08-11 · Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
2026-08-03 · Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
2026-07-14 · Autolus Therapeutics (AUTL) Grants Inducement Awards to New Employees
Price (daily)
Full chart · RSI · MACD · patterns